BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 17654737)

  • 1. Exacerbation of experimental autoimmune encephalomyelitis after withdrawal of phenytoin and carbamazepine.
    Black JA; Liu S; Carrithers M; Carrithers LM; Waxman SG
    Ann Neurol; 2007 Jul; 62(1):21-33. PubMed ID: 17654737
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phenytoin protects central axons in experimental autoimmune encephalomyelitis.
    Black JA; Waxman SG
    J Neurol Sci; 2008 Nov; 274(1-2):57-63. PubMed ID: 18485368
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sodium channels contribute to microglia/macrophage activation and function in EAE and MS.
    Craner MJ; Damarjian TG; Liu S; Hains BC; Lo AC; Black JA; Newcombe J; Cuzner ML; Waxman SG
    Glia; 2005 Jan; 49(2):220-9. PubMed ID: 15390090
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term protection of central axons with phenytoin in monophasic and chronic-relapsing EAE.
    Black JA; Liu S; Hains BC; Saab CY; Waxman SG
    Brain; 2006 Dec; 129(Pt 12):3196-208. PubMed ID: 16931536
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tapered withdrawal of phenytoin removes protective effect in EAE without inflammatory rebound and mortality.
    Liu S; Zwinger P; Black JA; Waxman SG
    J Neurol Sci; 2014 Jun; 341(1-2):8-12. PubMed ID: 24690348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phenytoin protects spinal cord axons and preserves axonal conduction and neurological function in a model of neuroinflammation in vivo.
    Lo AC; Saab CY; Black JA; Waxman SG
    J Neurophysiol; 2003 Nov; 90(5):3566-71. PubMed ID: 12904334
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuropathic pain behaviours in a chronic-relapsing model of experimental autoimmune encephalomyelitis (EAE).
    Olechowski CJ; Truong JJ; Kerr BJ
    Pain; 2009 Jan; 141(1-2):156-64. PubMed ID: 19084337
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Block of a subset of sodium channels exacerbates experimental autoimmune encephalomyelitis.
    Stevens M; Timmermans S; Bottelbergs A; Hendriks JJ; BrĂ´ne B; Baes M; Tytgat J
    J Neuroimmunol; 2013 Aug; 261(1-2):21-8. PubMed ID: 23735284
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amelioration of autoimmune neuroinflammation by recombinant human alpha-fetoprotein.
    Irony-Tur-Sinai M; Grigoriadis N; Lourbopoulos A; Pinto-Maaravi F; Abramsky O; Brenner T
    Exp Neurol; 2006 Mar; 198(1):136-44. PubMed ID: 16423348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroprotection of axons with phenytoin in experimental allergic encephalomyelitis.
    Lo AC; Black JA; Waxman SG
    Neuroreport; 2002 Oct; 13(15):1909-12. PubMed ID: 12395089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Steroid protection in the experimental autoimmune encephalomyelitis model of multiple sclerosis.
    Garay L; Gonzalez Deniselle MC; Gierman L; Meyer M; Lima A; Roig P; De Nicola AF
    Neuroimmunomodulation; 2008; 15(1):76-83. PubMed ID: 18667803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. VEGF and angiogenesis in acute and chronic MOG((35-55)) peptide induced EAE.
    Roscoe WA; Welsh ME; Carter DE; Karlik SJ
    J Neuroimmunol; 2009 Apr; 209(1-2):6-15. PubMed ID: 19233483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Delayed administration of erythropoietin and its non-erythropoietic derivatives ameliorates chronic murine autoimmune encephalomyelitis.
    Savino C; Pedotti R; Baggi F; Ubiali F; Gallo B; Nava S; Bigini P; Barbera S; Fumagalli E; Mennini T; Vezzani A; Rizzi M; Coleman T; Cerami A; Brines M; Ghezzi P; Bianchi R
    J Neuroimmunol; 2006 Mar; 172(1-2):27-37. PubMed ID: 16337691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of C5a in the brain does not exacerbate experimental autoimmune encephalomyelitis.
    Reiman R; Campos Torres A; Martin BK; Ting JP; Campbell IL; Barnum SR
    Neurosci Lett; 2005 Dec; 390(3):134-8. PubMed ID: 16154690
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phenytoin at optimum doses ameliorates experimental autoimmune encephalomyelitis via modulation of immunoregulatory cells.
    Hashiba N; Nagayama S; Araya SI; Inada H; Sonobe Y; Suzumura A; Matsui M
    J Neuroimmunol; 2011 Apr; 233(1-2):112-9. PubMed ID: 21237519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Abnormal sodium channel distribution in optic nerve axons in a model of inflammatory demyelination.
    Craner MJ; Lo AC; Black JA; Waxman SG
    Brain; 2003 Jul; 126(Pt 7):1552-61. PubMed ID: 12805113
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The influence of uric acid treatments on liver glutathione system prevent oxidative damages in experimental autoimmune encephalomyelitis mice.
    Allameh A; Maleklou N; Zargari M; Sanati MH
    Neurosci Lett; 2008 Jul; 439(1):111-5. PubMed ID: 18501514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of CNTF in Mesenchymal Stem Cells reduces demyelination and induces clinical recovery in experimental autoimmune encephalomyelitis mice.
    Lu Z; Hu X; Zhu C; Wang D; Zheng X; Liu Q
    J Neuroimmunol; 2009 Jan; 206(1-2):58-69. PubMed ID: 19081144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Upregulation and colocalization of p75 and Nav1.8 in Purkinje neurons in experimental autoimmune encephalomyelitis.
    Damarjian TG; Craner MJ; Black JA; Waxman SG
    Neurosci Lett; 2004 Oct; 369(3):186-90. PubMed ID: 15464262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Soluble egg antigen from Schistosoma japonicum modulates the progression of chronic progressive experimental autoimmune encephalomyelitis via Th2-shift response.
    Zheng X; Hu X; Zhou G; Lu Z; Qiu W; Bao J; Dai Y
    J Neuroimmunol; 2008 Feb; 194(1-2):107-14. PubMed ID: 18207251
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.